Graft versus host disease

PUBLICATIONS from the Nghiem Lab related to Graft versus host disease & skin inflammation


Dr Nghiem sees patients Tuesday mornings at the Seattle Cancer Care Alliance. For patient care issues please call: 206-288-1024.

  1. Nghiem P. The "Drug vs Graft-vs-Host Disease" Conundrum Gets Tougher but There is an Answer: The Challenge to Dermatologists. Arch Dermatol 2001, 137:75-76. [pdf]

  2. Nghiem P. "Topical Immunomodulators?": Introducing old friends and a new ally, tacrolimus. J Am Acad Dermatol 2001, 44:111-113. [pdf]

  3. Nghiem P, Pearson G, Langley R. Tacrolimus and Pimecrolimus: From Clever Microbes to Inhibiting Calcineurin and Treating Atopic Dermatitis. J Am Acad Dermatol. 2002, 46:228-41. [pdf]

  4. Marra DE, McKee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol. 2004. 51(4):543-6. [pdf]
  1. Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected accute graft-vs-host disease: results of decision analysis. Arch Deramatol. 2006. 142(2):175-82. [pdf]

[back to index]